Cargando…

New Mechanisms in Glucose Control.

New Mechanisms in Glucose Control presents a clear overview of the new drugs and treatment therapies that have been developed in recent years to help improve glycaemic management for the diabetic patient, namely the incretin mimetics (GLP-1 agonists) and DPP-4 inhibitors. It also considers other dru...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Barnett, Anthony H.
Otros Autores: Grice, Jenny
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Chicester : Wiley, 2013.
Edición:2nd ed.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover; Contents; Title page; Copyright; Preface; Chapter 1: Epidemiology and Pathogenesis of Type 2 Diabetes; The current prevalence of diabetes; Factors driving the type 2 diabetes epidemic; Pathogenesis of type 2 diabetes; References; Chapter 2: Overview of Current Diabetes Management; Recommended targets for glycaemic control; Pros and cons of existing non-insulin antidiabetes therapies; Why are new drugs needed for the treatment of type 2 diabetes?; References; Chapter 3: The Incretin System; References; Chapter 4: The Incretin Mimetics; Exenatide; Liraglutide.
  • Place in therapy of the incretin mimeticsReferences; Chapter 5: Dipeptidyl Peptidase-4 Inhibitors; Mechanism of action; DPP-4 inhibitor clinical efficacy; Vildagliptin; Saxagliptin; DPP-4 inhibitor safety and tolerability; DPP-4 inhibitor advantages and disadvantages; DPP-4 inhibitor current indications; Place in therapy of the DPP-4 inhibitors; References; Chapter 6: Sodium-glucose Cotransporter-2 Inhibitors; Dapagliflozin; Safety and tolerability; SGLT-2 inhibitor advantages and disadvantages; References; Chapter 7: Pipeline Diabetes Therapies; Taspoglutide; Linagliptin.
  • Bile acid receptor agonistsGlucokinase activators; Sirtuins; Sodium-glucose cotransporter-1 inhibitors; Sodium-glucose cotransporter-2 antisense inhibitors; Glucose-dependent insulinotropic polypeptide agonists and antagonists; Glucagon receptor antagonists; References; Chapter 8: Bariatric Surgery for the Treatment of Type 2 Diabetes; Potential mechanisms of diabetes resolution after bariatric surgery; Efficacy of bariatric surgery for the treatment of type 2 diabetes; Considerations; References; Chapter 9: Organization of Diabetes Care; Managing diabetes in primary care.
  • Delivery of diabetes care closer to homeStructured patient education programmes; References; Index.